Condensed Statements of Shareholders' Deficiency - USD ($)	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853
Beginning balance	$ (930,624)	$ (835,505)
Net loss	$ (22,773)	(21,167)
Ending balance (in shares)	1,233,853
Ending balance	$ (953,397)	$ (856,672)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853	1,233,853
Beginning balance	$ 1,233	$ 1,233
Ending balance (in shares)	1,233,853	1,233,853
Ending balance	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	81,323	81,323
Ending balance	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(1,013,180)	(918,061)
Net loss	(22,773)	(21,167)
Ending balance	$ (1,035,953)	$ (939,228)